On February 26, 2019, MAPS Public Benefit Corporation (MAPS PBC) staff and researchers gathered for a publication meeting and data unblinding for the MAPS-sponsored clinical trial of smoked marijuana (cannabis) as a treatment for PTSD symptoms in veterans. All 76 participants have completed treatment, and the data from the study are now being analyzed and prepared for publication later this year in a peer-reviewed biomedical journal. • Learn More